Acadia Receives FDA Priority Review For Parkinson's Drug By: TalkMarkets November 03, 2015 at 12:25 PM EST Acadia receives FDA Priority Review for Parkinson's Drug; Shares closed up 15% yesterday. Read More >> Related Stocks: Acadia Pharmaceutica